Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Solid Biosciences Inc. - Common Stock (NQ: SLDB )

5.730 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.730
Bid (Size) 5.540 (1)
Ask (Size) 5.980 (1)
Prev. Close 5.730
Today's Range 5.730 - 5.730
52wk Range 2.880 - 15.05
Shares Outstanding 19,601,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments. 
Via Stocktwits
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Solid Biosciences just saw a 32% move to the upside after its trial results impressed. What's next for this firm that analysts still see massive potential in? 
Via MarketBeat
Exposures Product Safety

Performance

YTD
+46.92%
+46.92%
1 Month
+66.57%
+66.57%
3 Month
+14.37%
+14.37%
6 Month
-23.50%
-23.50%
1 Year
-49.74%
-49.74%

More News

Read More
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?
Via Stocktwits
Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data
Via Benzinga
Stocks Quiet As S&P 500 Nears All-Time High
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Tuesday's session: gap up and gap down stocks
Via Chartmill
Wondering what's happening in today's pre-market session?
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Via Benzinga
Exposures Product Safety
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst
Via Benzinga
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024
Via InvestorPlace
This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
Via Investor's Business Daily
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Via Investor's Business Daily
Exposures Product Safety
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
Via InvestorPlace
SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.